Suraksha Diagnostic's Q3 FY 2025-26 Quarterly Results
- 06 Feb 2026
Result Summary
- Suraksha Diagnostic Ltd reported a 1.6% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 30.3%.
- Its expenses for the quarter were up by 0.1% QoQ and 29.4% YoY.
- The net profit decreased 18.0% QoQ and increased 21.1% YoY.
- The earnings per share (EPS) of Suraksha Diagnostic Ltd stood at 1.44 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 78.31 | 79.58 | 60.11 | -1.6% | 30.3% |
Total Expenses | 67.39 | 67.33 | 52.07 | 0.1% | 29.4% |
Profit Before Tax | 10.06 | 12.05 | 8.05 | -16.5% | 25.0% |
Tax | 2.82 | 3.22 | 2.06 | -12.4% | 36.9% |
Profit After Tax | 7.24 | 8.83 | 5.98 | -18.0% | 21.1% |
Earnings Per Share | 1.44 | 1.73 | 1.18 | -16.8% | 22.0% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Suraksha Diagnostic Ltd operates within the healthcare industry, primarily focusing on providing diagnostic and testing services. The company offers a range of medical tests and diagnostic procedures, catering to a broad spectrum of clients, including hospitals, clinics, and individual patients. Suraksha Diagnostic Ltd is known for its commitment to accuracy and timely delivery of diagnostic results, which is critical in the healthcare industry. The company may have been involved in recent developments such as expanding its service offerings, increasing its geographical reach, or implementing advanced diagnostic technologies. However, specific recent developments regarding the company are not available in the provided data.
Revenue
In the third quarter of fiscal year 2026 (Q3FY26), Suraksha Diagnostic Ltd reported a total income of ₹78.31 crores. This represents a slight decrease of 1.6% compared to the previous quarter (Q2FY26), where the total income was ₹79.58 crores. However, when compared year-over-year (YoY) to the third quarter of fiscal year 2025 (Q3FY25), the total income shows a significant growth of 30.3%, increasing from ₹60.11 crores. This YoY growth indicates an upward trend in the company's revenue generation over the past year.
Profitability
The company's profit before tax (PBT) for Q3FY26 stood at ₹10.06 crores, which is a decrease of 16.5% compared to the previous quarter (Q2FY26), where the PBT was ₹12.05 crores. Despite this quarterly decline, the PBT shows a 25.0% increase YoY, up from ₹8.05 crores in Q3FY25. The tax expenses for Q3FY26 were ₹2.82 crores, representing a 12.4% decrease from the previous quarter's tax of ₹3.22 crores. Year-over-year, the tax expenses increased by 36.9%, up from ₹2.06 crores in Q3FY25. Consequently, the profit after tax (PAT) for Q3FY26 was ₹7.24 crores, which is an 18.0% decrease from the previous quarter but a 21.1% increase from the same quarter in the previous year. The earnings per share (EPS) for Q3FY26 was ₹1.44, showing a quarterly decrease of 16.8% from ₹1.73 in Q2FY26 and an annual increase of 22.0% from ₹1.18 in Q3FY25.
Operating Metrics
Suraksha Diagnostic Ltd reported total expenses of ₹67.39 crores in Q3FY26, which remained relatively stable with a slight increase of 0.1% from Q2FY26, where the expenses were ₹67.33 crores. Year-over-year, the total expenses increased by 29.4% from ₹52.07 crores in Q3FY25. The company’s consistent expense management over the quarters, combined with the YoY increase, reflects adjustments or expansions in its operations. The company's ability to maintain its expense levels while experiencing revenue growth suggests operational resilience in a competitive industry. However, detailed operational metrics such as specific cost controls or efficiency measures are not available in the provided data.